Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves Menu

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Annals of Surgical Oncology|September 5, 2025
ASO Visual Abstract: Multimodal Management of Retroperitoneal Lymph Node Metastases in Colorectal Cancer: A Single-Center Retrospective AnalysisArthur Houbiers, Remy Barbe, Jerome Durand-Labrunie, et al.
Targeted Oncology|April 13, 2021
The Activity of Crizotinib in Chemo-Refractory MET-Amplified Esophageal and Gastric Adenocarcinomas: Results from the AcSé-Crizotinib ProgramThomas Aparicio, Nathalie Cozic, Christelle de la Fouchardière, et al.
European Journal of Cancer (Oxford, England : 1990)|March 19, 2024
Imaging-guided prognostic score-based approach to assess the benefits of combotherapy versus monotherapy with immune checkpoint inhibitors in metastatic MSI-H colorectal cancer patientsRémy Barbe, Younes Belkouchi, Yves Menu, et al.
Journal of Magnetic Resonance Imaging : JMRI|February 15, 2022
Evaluating the Impact of Peer Review on the Completeness of Reporting in Imaging Diagnostic Test Accuracy ResearchSakib Kazi, Robert A Frank, Jean-Paul Salameh, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 21, 2018
Diagnostic Accuracy of Noninvasive Markers of Steatosis, NASH, and Liver Fibrosis in HIV-Monoinfected Individuals at Risk of Nonalcoholic Fatty Liver Disease (NAFLD): Results From the ECHAM StudyMaud Lemoine, Lambert Assoumou, Stephane De Wit, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 18, 2022
Screening HIV Patients at Risk for NAFLD Using MRI-PDFF and Transient Elastography: A European Multicenter Prospective StudyMaud Lemoine, Lambert Assoumou, Pierre-Marie Girard, et al.
The Lancet. Oncology|June 1, 2026
[<sup>177</sup>Lu]Lu-dota-tate versus sunitinib in patients with metastatic progressive neuroendocrine tumours of the pancreas (OCLURANDOM): a randomised, controlled, phase 2 trialEric Baudin, Alice Durand, Amandine Beron, et al.
The Lancet. Gastroenterology & Hepatology|February 23, 2025
[<sup>18</sup>F]fluorodeoxyglucose and [<sup>18</sup>F]fluorocholine PET-CT for staging optimisation and treatment modification in hepatocellular carcinoma (PET-HCC01): a prospective multicentre studyJean-Charles Nault, Marouane Boubaya, Myriam Wartski, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Annals of Surgical Oncology|September 5, 2025
ASO Visual Abstract: Multimodal Management of Retroperitoneal Lymph Node Metastases in Colorectal Cancer: A Single-Center Retrospective AnalysisArthur Houbiers, Remy Barbe, Jerome Durand-Labrunie, et al.
Targeted Oncology|April 13, 2021
The Activity of Crizotinib in Chemo-Refractory MET-Amplified Esophageal and Gastric Adenocarcinomas: Results from the AcSé-Crizotinib ProgramThomas Aparicio, Nathalie Cozic, Christelle de la Fouchardière, et al.
European Journal of Cancer (Oxford, England : 1990)|March 19, 2024
Imaging-guided prognostic score-based approach to assess the benefits of combotherapy versus monotherapy with immune checkpoint inhibitors in metastatic MSI-H colorectal cancer patientsRémy Barbe, Younes Belkouchi, Yves Menu, et al.
Journal of Magnetic Resonance Imaging : JMRI|February 15, 2022
Evaluating the Impact of Peer Review on the Completeness of Reporting in Imaging Diagnostic Test Accuracy ResearchSakib Kazi, Robert A Frank, Jean-Paul Salameh, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 21, 2018
Diagnostic Accuracy of Noninvasive Markers of Steatosis, NASH, and Liver Fibrosis in HIV-Monoinfected Individuals at Risk of Nonalcoholic Fatty Liver Disease (NAFLD): Results From the ECHAM StudyMaud Lemoine, Lambert Assoumou, Stephane De Wit, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 18, 2022
Screening HIV Patients at Risk for NAFLD Using MRI-PDFF and Transient Elastography: A European Multicenter Prospective StudyMaud Lemoine, Lambert Assoumou, Pierre-Marie Girard, et al.
The Lancet. Oncology|June 1, 2026
[<sup>177</sup>Lu]Lu-dota-tate versus sunitinib in patients with metastatic progressive neuroendocrine tumours of the pancreas (OCLURANDOM): a randomised, controlled, phase 2 trialEric Baudin, Alice Durand, Amandine Beron, et al.
The Lancet. Gastroenterology & Hepatology|February 23, 2025
[<sup>18</sup>F]fluorodeoxyglucose and [<sup>18</sup>F]fluorocholine PET-CT for staging optimisation and treatment modification in hepatocellular carcinoma (PET-HCC01): a prospective multicentre studyJean-Charles Nault, Marouane Boubaya, Myriam Wartski, et al.
Pageof 6